ENOCHIAN BIOSCIENCES INC (ENOB)
US29350E1047 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | 2019 (2019-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.95M | 9.17M | 20.66M | 8.70M | 12.30M | |||
| Receivables | N/A | N/A | 1.64K | 0.00 | 0.00 | |||
| Other Current Assets | 978.88K | 393.00K | 232.94K | 200.00K | 200.00K | |||
| Total Current Assets | 3.93M | 9.57M | 20.90M | 8.90M | 12.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.49M | 1.74M | 2.16M | 2.50M | 700.00K | |||
| Goodwill | 11.64M | 11.64M | 11.64M | 11.60M | 11.60M | |||
| Intangibles | 61.61M | 61.62M | 154.89M | 154.90M | 154.90M | |||
| Other Non-Current Assets | 58.59K | 68.64K | 20.98K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 74.80M | 75.07M | 168.71M | 169.20M | 167.40M | |||
| TOTAL ASSETS | 78.73M | 84.63M | 189.61M | 178.10M | 179.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 6.00M | 1.20M | N/A | N/A | N/A | |||
| Accrued Expenses | 799.95K | 1.29M | 1.47M | 700.00K | 300.00K | |||
| Accounts Payable | 4.47M | 1.40M | 320.56K | 600.00K | 800.00K | |||
| Other Current Liabilities | 501.05K | 2.56M | 90.60K | N/A | N/A | |||
| Total Current Liabilities | 11.77M | 6.45M | 1.89M | 1.30M | 1.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 4.58M | 5.78M | 5.80M | 0.00 | |||
| Other Non-Current Liabilities | 829.21K | 985.70K | 7.28M | 4.70M | 5.70M | |||
| Total Non-Current Liabilities | 829.22K | 5.56M | 13.06M | 10.50M | 5.70M | |||
| TOTAL LIABILITIES | 12.60M | 12.01M | 14.94M | 11.80M | 6.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -220.83M | -204.35M | -90.91M | -64.20M | -52.80M | |||
| Additional Paid In Capital | 286.99M | 276.99M | 265.58M | 230.50M | 225.80M | |||
| Common Shares | 5.80K | 5.30K | 5.22K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -32.39K | -30.44K | -10.83K | 0.00 | 100.00K | |||
| Shares Outstanding | 57.98M | 53.01M | 52.22M | 46.50M | 45.30M | |||
| Tangible Book Value per Share | -0.12 | -0.01 | 0.16 | -0.00 | 0.15 | |||
| Total Shareholders' Equity | 66.13M | 72.62M | 174.66M | 166.30M | 173.10M | |||
| TOTAL LIABILITIES AND EQUITY | 78.73M | 84.63M | 189.61M | 178.10M | 179.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.06 | 0.03 | 0.03 | N/A | |||
| Current Ratio | 0.33 | 1.48 | 11.08 | 6.85 | 11.36 | |||
| Return On Assets (ROA) | -135.55% | -134.03% | -14.09% | -6.41% | -10.02% | |||
| Return On Equity (ROE) | -161.39% | -156.20% | -15.30% | -6.87% | -10.41% | |||
All data in USD